NEW YORK (GenomeWeb) – Lifebit, a London-based maker of advanced genomic analysis technology, has raised $3 million in seed funding and introduced its first product. Pentech and Connect Ventures led the investment, with participation from Beacon Capital and crowdsourcing angel investment site Tiny VC.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.